© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCV2 10MCG TRS-SUCR 1 | Medium Descr | IMM ADMN SARSCOV2 10MCG/0.2ML TRIS-SUCROSE 1ST | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-04-18 | Note | Changes made to dosing information. |
| 2023-04-18 | Note | These codes (previously associated with 0071A) are no longer authorized for use in the United States: 0072A, 0073A, 0074A, 91300, 91305, 91307, 91308. |
| 2023-04-18 | Note | No longer authorized for use in the United States. |
| 2023-01-01 | Added | First appearance in codebook. |
| 2022-12-08 | Note | AMA guideline changed to include 91317. Published to website 2021-12-09. Received FDA approval effective retroactively to 2022-12-08. |
| 2022-10-12 | Note | AMA Guideline changed. 91315 received FDA approval. |
| 2022-08-31 | Note | AMA guideline changed to include 91312 & 91315 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2022-08-31 | Note | AMA Guideline changed. 91312 received FDA approval effective immediately. |
| 2022-08-31 | Note | Changes made to vaccine name, product & dosing information, & patient age (5-11). |
| 2022-06-17 | Note | AMA Guideline changed. 91308 received FDA approval. |
| 2022-05-17 | Note | AMA Guideline changed. 0074A received FDA approval. |
| 2022-04-26 | Note | AMA guideline changed to include 0074A effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2022-02-01 | Note | AMA guideline changed to include 91308 effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2022-01-03 | Note | AMA guideline changed to include 0073A. Published to website 2021-01-12. Received FDA approval effective retroactively to 2022-01-03 |
| 2021-10-29 | Note | AMA Guideline changed. 0072A, 91305, 91307 received FDA approval. |
| 2021-10-29 | Added | FDA approval received. |
| 2021-10-06 | Note | AMA guideline added. Includes 91300; published & approved prior to addition of 0071A. |
| 2021-10-06 | Note | AMA guideline added and includes 0072A & 91305, 91307, effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2021-10-06 | Added | Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration. |